{"id":28018,"date":"2026-01-27T16:16:18","date_gmt":"2026-01-27T23:16:18","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=28018"},"modified":"2026-01-28T12:24:04","modified_gmt":"2026-01-28T19:24:04","slug":"ivig-for-major-burns-associated-secondary-immunosuppression","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/","title":{"rendered":"IgIV para la inmunosupresi\u00f3n secundaria asociada a quemaduras graves"},"content":{"rendered":"\n<p>One of the most severe forms of trauma that you can experience is major burns. Beyond the visible damage to skin and tissues, major burns can deeply disrupt your immune system, causing secondary immunosuppression. As a result, you become more vulnerable to serious infections, sepsis, and multiple organ failure [<a href=\"https:\/\/doi.org\/10.1186\/cc6102\">1<\/a>]. In fact, infections are one of the leading causes of death in major burn patients.<\/p>\n\n\n\n<div  id=\"call-to-action-67cccabcf1c4d0b1f598038b6e14b7fd\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tDo You Qualify for $0 Copay?\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tTalk to a Specialist to Find Out\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Fortunately, over the years, burn care has improved a lot. Advances in surgical techniques, intensive care, and infection control have improved survival rates. Besides these advancements, <a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/ivig\/\">intravenous immunoglobulin (IVIG)<\/a> has emerged as an effective supportive therapy for managing burn-related immunosuppression. In this article, we\u2019ll explore everything you need to know about IVIG for major burn-associated secondary immunosuppression.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#Major_Burns_Associated_Secondary_Immunosuppression_Overview\" >Major Burns Associated Secondary Immunosuppression: Overview<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#Signs_and_Symptoms_of_Burn-Related_Immunosuppression\" >Signs and Symptoms of Burn-Related Immunosuppression<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#Treatment_Options_for_Major_Burns_Associated_Secondary_Immunosuppression\" >Treatment Options for Major Burns Associated Secondary Immunosuppression<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#How_Does_IVIG_Help_Patients_With_Major_Burns_Associated_Secondary_Immunosuppression\" >How Does IVIG Help Patients With Major Burns Associated Secondary Immunosuppression?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#Effectiveness_of_IVIG_for_Major_Burns_Associated_Secondary_Immunosuppression_What_Studies_Say\" >Effectiveness of IVIG for Major Burns Associated Secondary Immunosuppression: What Studies Say<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#Who_Should_Take_IVIG_for_Major_Burns_Associated_Secondary_Immunosuppression\" >Who Should Take IVIG for Major Burns Associated Secondary Immunosuppression?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#Risks_and_Limitations\" >Risks and Limitations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#The_Bottom_Line\" >The Bottom Line<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Major_Burns_Associated_Secondary_Immunosuppression_Overview\"><\/span>Major Burns Associated Secondary Immunosuppression: Overview<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>In normal conditions, your skin acts as a physical barrier against bacteria, viruses, and fungi. In major burns (burns covering more than 20-30% of total body surface area), this barrier is severely compromised.<\/p>\n\n\n\n<p>Besides this, just immediately after a burn, your body enters a strong inflammatory state. In this state, your body releases massive amounts of stress hormones and inflammatory substances. Although this response is initially protective, it does not last. Soon, your immune system becomes overwhelmed and overstimulated. As a result, immune cells such as T lymphocytes, B cells, and <a href=\"https:\/\/my.clevelandclinic.org\/health\/body\/22313-neutrophils\">neutrophils<\/a> either stop working properly or decrease in number [<a href=\"https:\/\/doi.org\/10.3390\/cells12030345\">2<\/a>].<\/p>\n\n\n\n<p>This immune dysfunction is known as secondary immunosuppression. Patients in this state are at a much higher risk of developing infections. Their wound may also heal more slowly, and in severe cases, this can lead to life-threatening infections such as sepsis.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Signs_and_Symptoms_of_Burn-Related_Immunosuppression\"><\/span>Signs and Symptoms of Burn-Related Immunosuppression<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>In major burn patients, secondary immunosuppression is not always apparent. However, the following warning signs may indicate its presence [<a href=\"https:\/\/doi.org\/10.1186\/cc6102\">1<\/a>][<a href=\"https:\/\/doi.org\/10.3390\/cells12030345\">2<\/a>]:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Frequent or persistent wound infections<\/li>\n\n\n\n<li>Frequent episodes of pneumonia or bloodstream infections<\/li>\n\n\n\n<li>Delayed wound healing<\/li>\n\n\n\n<li>Sepsis<\/li>\n\n\n\n<li>Prolonged hospital or ICU stay<\/li>\n\n\n\n<li>Increased need for antibiotics<\/li>\n<\/ul>\n\n\n\n<p>Infections remain one of the leading causes of death in major burn patients. That\u2019s why early immune support is very important.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Treatment_Options_for_Major_Burns_Associated_Secondary_Immunosuppression\"><\/span>Treatment Options for Major Burns Associated Secondary Immunosuppression<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>There is no single cure for major burn-related immunosuppression. The current standard of treatment focuses on infection prevention, treatment, and supportive care. Here are some of the standard treatment options [<a href=\"https:\/\/doi.org\/10.1128\/cmr.19.2.403-434.2006\">3<\/a>][<a href=\"https:\/\/www.uptodate.com\/contents\/emergency-care-of-moderate-and-severe-thermal-burns-in-adults?utm_source=copilot.com\">4<\/a>]:<\/p>\n\n\n\n<p><strong>Early Wound Excision and Skin Grafting:<\/strong> Your doctor will promptly remove damaged tissues and perform skin grafting to reduce bacterial growth and lower the risk of infections.<\/p>\n\n\n\n<p><strong>Broad-Spectrum Antibiotics:<\/strong> Doctors use antibiotics to treat or prevent infections.<\/p>\n\n\n\n<p><strong>Nutritional Support: <\/strong>Diets rich in protein, vitamins, and micronutrients will support your immune function and promote wound healing.<\/p>\n\n\n\n<p><strong>Strict Infection Control Measures:<\/strong> Special infection control practices (sterile wound care, isolation when needed, etc.) in the burn unit help minimize infection risks.<\/p>\n\n\n\n<p>Despite these standard measures, many patients still develop immune dysfunction. In such cases, intravenous immunoglobulin (IVIG) serves as an important supportive therapy.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-00bcacd1e3e048f95d272f341350cdf9\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet IVIG Copay Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Contact Us<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_IVIG_Help_Patients_With_Major_Burns_Associated_Secondary_Immunosuppression\"><\/span>How Does IVIG Help Patients With Major Burns Associated Secondary Immunosuppression?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"315\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/home-infusion-1.jpg\" alt=\"A patient at home receiving IVIG for Major Burns Associated Secondary Immunosuppression\" class=\"wp-image-28022\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/home-infusion-1.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/home-infusion-1-300x225.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/home-infusion-1-16x12.jpg 16w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/home-infusion-1-86x65.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/home-infusion-1-167x125.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/home-infusion-1-280x210.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/home-infusion-1-370x278.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Intravenous immunoglobulin (IVIG) is a purified blood product that contains <a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/immunoglobulins-ig\/\">antibodies<\/a> from thousands of healthy plasma donors. When given intravenously, it provides passive immune support. In major burn patients with immune dysfunction, IVIG can support the immune system in several ways:<\/p>\n\n\n\n<p><strong>It Restores Antibody Levels:<\/strong> Major burns can reduce antibody levels and weaken antibody function. IVIG provides ready-made antibodies that help neutralize bacteria and toxins [<a href=\"https:\/\/doi.org\/10.1056\/nejmra993360\">5<\/a>].<\/p>\n\n\n\n<p><strong>It Reduces Infection Rates:<\/strong> Burn patients are highly vulnerable to serious infections such as <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/sepsis\/symptoms-causes\/syc-20351214\">sepsis<\/a>. Studies suggest that IVIG can reduce the frequency and severity of infections by strengthening your immune system [<a href=\"https:\/\/doi.org\/10.1097\/01.bcr.0000245421.54312.36\">6<\/a>].<\/p>\n\n\n\n<p><strong>It Modulates Excessive Inflammation:<\/strong> Burn injuries trigger uncontrolled inflammatory cytokine release. IVIG helps regulate this response by reducing harmful inflammation [<a href=\"https:\/\/rheumatology.org.au\/For-Patients\/Adult-Medication-Information\/H-M\/IV-Immunuglobulin?utm_source=copilot.com\">7<\/a>].<\/p>\n\n\n\n<p><strong>It Improves Immune Cell Functions:<\/strong> IVIG enhances the function of key immune cells, such as neutrophils and macrophages [<a href=\"https:\/\/doi.org\/10.1056\/nejmra993360\">5<\/a>].<\/p>\n\n\n\n<p><strong>It May Reduce Sepsis-Related Mortality:<\/strong> Some evidence suggests that IVIG may lower death rates in major burn patients by decreasing infection-related complications [<a href=\"https:\/\/doi.org\/10.1097\/01.bcr.0000245421.54312.36\">6<\/a>].<\/p>\n\n\n\n<p>Overall, IVIG is not a replacement for standard burn treatment. But doctors can use it as part of a comprehensive treatment plan to significantly strengthen immune defense in patients with major burn-related secondary immunosuppression.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Effectiveness_of_IVIG_for_Major_Burns_Associated_Secondary_Immunosuppression_What_Studies_Say\"><\/span>Effectiveness of IVIG for Major Burns Associated Secondary Immunosuppression: What Studies Say<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>In recent years, many studies have been conducted on IVIG use in burn-related immunosuppression. However, the overall results remain mixed. Most of the evidence came from small clinical trials and observational studies rather than large, well-controlled trials.<\/p>\n\n\n\n<p>Many studies have shown the benefits of using IVIG in patients with major burns. For example, one study concluded that patients treated with IVIG in addition to antibiotic therapy had a significantly lower risk of death due to infections [<a href=\"http:\/\/www.medbc.com\/annals\/review\/vol_6\/num_1\/text\/vol6n1p20.htm\">12<\/a>]. Similarly, another study suggested that IVIG can reduce infection rates in burn patients [<a href=\"https:\/\/doi.org\/10.1007\/bf01646129\">9<\/a>]. A severe complication of major burn is sepsis. It is a life-threatening infection. According to a study, IVIG is an effective adjunct therapy in treating sepsis [<a href=\"https:\/\/doi.org\/10.3390\/ijms21155543\">8<\/a>].&nbsp;<\/p>\n\n\n\n<p>In addition to reducing infections, IVIG may help correct underlying immune deficiencies caused by major burns. Severe burns typically cause a rapid reduction in immunoglobulin (IgG) levels. A study suggested that IVIG administration can correct low IgG levels [<a href=\"https:\/\/doi.org\/10.1016\/0305-4179(89)90132-0\">11<\/a>]. Also, some non-burn specific studies showed that IVIG can improve immune functions, such as enhancing neutrophil activity and balancing harmful inflammatory cytokines [<a href=\"https:\/\/rheumatology.org.au\/For-Patients\/Adult-Medication-Information\/H-M\/IV-Immunuglobulin?utm_source=copilot.com\">7<\/a>][<a href=\"https:\/\/doi.org\/10.1161\/circresaha.112.266411\">10<\/a>].<\/p>\n\n\n\n<p>However, not all studies showed clear benefits. Some research found no significant difference in infection rates or mortality between patients who received IVIG and those who did not [<a href=\"https:\/\/doi.org\/10.1016\/0305-4179(89)90132-0\">11<\/a>][<a href=\"https:\/\/doi.org\/10.1007\/978-3-642-77405-8_153\">13<\/a>].<\/p>\n\n\n\n<p>In summary, IVIG is not a universally effective treatment for all burn patients. However, the available evidence suggests it may be especially helpful in severely burned patients with frequent infections or signs of immune failure.<\/p>\n\n\n\n<div  id=\"call-to-action-1516ce2df5d2c96f1b449a2615e41228\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tConsult an IVIG Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_Should_Take_IVIG_for_Major_Burns_Associated_Secondary_Immunosuppression\"><\/span>Who Should Take IVIG for Major Burns Associated Secondary Immunosuppression?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>IVIG is not suited for every burn patient. Your doctor will consider IVIG if you:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Have extensive burns and experience repeated infections<\/li>\n\n\n\n<li>Had a history of low immunoglobulin levels<\/li>\n\n\n\n<li>Have sepsis that does not respond to standard therapy<\/li>\n\n\n\n<li>Show evidence of immune dysfunction<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risks_and_Limitations\"><\/span>Risks and Limitations<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>While IVIG is generally safe, it is not without drawbacks. It can cause some <a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/understanding-the-common-side-effects-of-ivig-treatment\/\">side effects<\/a>. Here are some of them [<a href=\"https:\/\/my.clevelandclinic.org\/health\/treatments\/ivig-intravenous-immunoglobulin\">14<\/a>]:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Headache<\/li>\n\n\n\n<li>Nausea and vomiting<\/li>\n\n\n\n<li>Chest and back pain<\/li>\n\n\n\n<li>Fever<\/li>\n\n\n\n<li>Muscle pain<\/li>\n\n\n\n<li>Allergic or infusion-related reactions<\/li>\n<\/ul>\n\n\n\n<p>In addition to side effects, IVIG has some limitations when used for major burn-related immune suppression. Here are some of them:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>It is not a replacement for antibiotics<\/li>\n\n\n\n<li>Benefits may vary between patients<\/li>\n\n\n\n<li>Limited high-quality evidence in the burn population<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_Bottom_Line\"><\/span>The Bottom Line<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Severe burns can weaken your immune system and cause life-threatening infections. IVIG may help some patients by supporting immune functions, but it is not recommended for all burn cases. When used carefully, IVIG can be a valuable addition to standard burn care.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Una de las formas m\u00e1s graves de trauma que se pueden experimentar son las quemaduras graves. Adem\u00e1s del da\u00f1o visible en la piel y los tejidos, las quemaduras graves pueden afectar gravemente el sistema inmunitario y causar inmunosupresi\u00f3n secundaria.<\/p>","protected":false},"author":7,"featured_media":28024,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[8],"class_list":["post-28018","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for Major Burns Associated Secondary Immunosuppression - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Comprehensive review of burn-induced immune and metabolic responses, infection risks, and evidence for IVIG use in severe burn and sepsis management.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for Major Burns Associated Secondary Immunosuppression - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Comprehensive review of burn-induced immune and metabolic responses, infection risks, and evidence for IVIG use in severe burn and sepsis management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-27T23:16:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-28T19:24:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"IVIG for Major Burns Associated Secondary Immunosuppression\",\"datePublished\":\"2026-01-27T23:16:18+00:00\",\"dateModified\":\"2026-01-28T19:24:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/\"},\"wordCount\":1118,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/ivig-patient.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/\",\"name\":\"IVIG for Major Burns Associated Secondary Immunosuppression - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/ivig-patient.jpg\",\"datePublished\":\"2026-01-27T23:16:18+00:00\",\"dateModified\":\"2026-01-28T19:24:04+00:00\",\"description\":\"Comprehensive review of burn-induced immune and metabolic responses, infection risks, and evidence for IVIG use in severe burn and sepsis management.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/ivig-patient.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/ivig-patient.jpg\",\"width\":1280,\"height\":853,\"caption\":\"IVIG patient receiving infusion at home\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/ivig-for-major-burns-associated-secondary-immunosuppression\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for Major Burns Associated Secondary Immunosuppression\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IgIV para la inmunosupresi\u00f3n secundaria asociada a quemaduras graves - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Revisi\u00f3n exhaustiva de las respuestas inmunes y metab\u00f3licas inducidas por quemaduras, riesgos de infecci\u00f3n y evidencia del uso de IgIV en el tratamiento de quemaduras graves y sepsis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG for Major Burns Associated Secondary Immunosuppression - AmeriPharma\u00ae Specialty Care","og_description":"Comprehensive review of burn-induced immune and metabolic responses, infection risks, and evidence for IVIG use in severe burn and sepsis management.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2026-01-27T23:16:18+00:00","article_modified_time":"2026-01-28T19:24:04+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"IVIG for Major Burns Associated Secondary Immunosuppression","datePublished":"2026-01-27T23:16:18+00:00","dateModified":"2026-01-28T19:24:04+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/"},"wordCount":1118,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/","url":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/","name":"IgIV para la inmunosupresi\u00f3n secundaria asociada a quemaduras graves - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg","datePublished":"2026-01-27T23:16:18+00:00","dateModified":"2026-01-28T19:24:04+00:00","description":"Revisi\u00f3n exhaustiva de las respuestas inmunes y metab\u00f3licas inducidas por quemaduras, riesgos de infecci\u00f3n y evidencia del uso de IgIV en el tratamiento de quemaduras graves y sepsis.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg","width":1280,"height":853,"caption":"IVIG patient receiving infusion at home"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/ivig-for-major-burns-associated-secondary-immunosuppression\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"IVIG for Major Burns Associated Secondary Immunosuppression"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"One of the most severe forms of trauma that you can experience is major burns. Beyond the visible damage to skin and tissues, major burns can deeply disrupt your immune system, causing secondary immunosuppression.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/01\/ivig-patient.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"One of the most severe forms of trauma that you can experience is major burns. Beyond the visible damage to skin and tissues, major burns can deeply disrupt your immune system, causing secondary immunosuppression.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/28018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=28018"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/28018\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/28024"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=28018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=28018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=28018"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}